Authors: Goldman, SC Holcenberg, JS Finklestein, JZ Hutchinson, R Kreissman, S Johnson, FL Tou, C Harvey, E Morris, E Cairo, MS

Citation: Sc. Goldman et al., A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis, BLOOD, 97(10), 2001, pp. 2998-3003

Authors: St Clair, EW Cohen, SB Lee, ML Fleischmann, RM Lee, SH Moreland, LW Olsen, NJ Pratt, PW Yocum, DE Heck, L Winkelhake, J Holcenberg, JS Shulman, MJ

Citation: Ew. St Clair et al., Treatment of rheumatoid arthritis with a DR4/1 peptide, J RHEUMATOL, 27(8), 2000, pp. 1855-1863

Authors: Frangoul, H Ames, MM Mosher, RB Reid, JM Krailo, MD Seibel, NL Shaw, DWW Steinherz, PG Whitlock, JA Holcenberg, JS

Citation: H. Frangoul et al., Phase I study of topotecan administered as a 21-day continuous infusion inchildren with recurrent solid tumors: A report from the Children's Cancer Group, CLIN CANC R, 5(12), 1999, pp. 3956-3962

Authors: Walsh, TJ Finberg, RW Arndt, C Hiemenz, J Schwartz, C Bodensteiner, D Pappas, P Seibel, N Greenberg, RN Dummer, S Schuster, M Holcenberg, JS

Citation: Tj. Walsh et al., Liposomal amphotericin B for empirical therapy in patients with persistentfever and neutropenia, N ENG J MED, 340(10), 1999, pp. 764-771

Authors: Hum, M Holcenberg, JS Tkaczewski, I Weaver, JW Wilson, J Kamen, BA

Citation: M. Hum et al., High-dose trimetrexate and minimal-dose leucovorin: A case for selective protection, CLIN CANC R, 4(12), 1998, pp. 2981-2984